Asitri Dashboard Search Clinical Trials
The U.S. National Library of Medicine provides a database of clinical trials worldwide. Use the fields below to search the database. Expand your results and select terms or phrases and right-click to search using Google, MalaCards, MedlinePlus, PubMed, or Wikipedia.
Saved Searches
Choose Search
Basic Search
Clinical Trials Search Results
Search History:
Count: 1266
Selected: 0
| NCT ID | Title | ||
|---|---|---|---|
| NCT02592330 | Limbal Stem Cell Deficiency (LSCD) Treatment With Cultivated Stem Cell (CALEC) Graft | ||
| NCT01184326 | Expanded Phase I Pazopanib and Everolimus in Advanced Solid Tumors and Previously Treated Advanced Urothelial Cancer | ||
| NCT06710548 | REVITALIZE: RCT to Reduce Fatigue in Adults With Ovarian Cancer on PARP Inhibitors | ||
| NCT03291730 | A Nurse Led Project to Introduce Hand Lettering as a Form of Creative Art Expression to Patients in an Ambulatory Oncology Setting | ||
| NCT05463848 | Surgical Pembro +/- Olaparib w TMZ for rGBM | ||
| NCT00136448 | High Dose Ara-C (HDAC) and Interleukin-2 (IL-2) for Patients With Acute Myelogenous Leukemia (AML) | ||
| NCT07027748 | Feasibility Study of Prolonged Administration of Naxitamab, Irinotecan, and Temozolomide for Patients With Relapsed or Refractory Neuroblastoma | ||
| NCT05423730 | Alcohol and Breast Cancer (ABC) Trial | ||
| NCT02337491 | Pembrolizumab +/- Bevacizumab for Recurrent GBM | ||
| NCT03887091 | Personal Web Page In Clinical Trial Participant Education | ||
| NCT01319591 | Comparison of Creatinine Clearance Calculation for Estimation of GFR in Patients Receiving HD Methotrexate | ||
| NCT03344965 | Olaparib In Metastatic Breast Cancer | ||
| NCT05629065 | Pathways to Advance Targeted and Helpful Serious Illness Conversations (PATH-SIC) | ||
| NCT02326974 | T-DM1+Pertuzumab in Pre-OP Early-Stage HER2+ BRCA | ||
| NCT00148720 | Capecitabine in Women With Operable Breast Cancer | ||
| NCT00570674 | Abraxane in Combination With Carboplatin, Erbitux and IMRT for Locally Advanced Squamous Cancer of the Head and Neck | ||
| NCT01177527 | Questionnaire and Tissue Banking For Multiple Myeloma, Waldenstrom Macroglobulinemia and Related Disorders | ||
| NCT02827773 | Improving Medication Adherence: A Study With Talking Pill Bottles | ||
| NCT00165373 | rhEndostatin Protein Involving Pediatric Patients With Cancer | ||
| NCT03364673 | Stepping Into Survivorship: Harnessing Behavioral Economics to Improve Quality of Life in Ovarian Cancer | ||
| NCT03316573 | Pembrolizumab in Neoplasms or Lymphomas | ||
| NCT01472627 | Effects of Bortezomib-Based Therapy on Cellular Immunity and Response to DC/Myeloma Fusion Vaccines in Vitro | ||
| NCT01562873 | Ruxolitinib in Patients With Breast Cancer | ||
| NCT05349227 | Comprehensive Outcomes for After Cancer Health | ||
| NCT02260531 | Cabozantinib +/- Trastuzumab In Breast Cancer Patients w/ Brain Metastases | ||
| NCT06034431 | Increasing Access to Definitive Treatment for Prostate Cancer | ||
| NCT01853748 | T-DM1 vs Paclitaxel/Trastuzumab for Breast (ATEMPT Trial) | ||
| NCT00250926 | Study of the Combination of Bortezomib, Dexamethasone, and Rituximab in Patients With Waldenstroms Macroglobulinemia | ||
| NCT00090857 | Letrozole in Preventing Breast Cancer in Postmenopausal Women | ||
| NCT06736548 | Sleep Treatment Education Program for Cancer Survivors: STEP-Together | ||
| NCT02251548 | A Phase II Study of Ibrutinib Plus FCR in Previously Untreated, Younger Patients With Chronic Lymphocytic Leukemia | ||
| NCT00137826 | Bevacizumab (Avastin) and Erlotinib (Tarceva) in Previously Treated Mesothelioma | ||
| NCT03482557 | Contrast Enhanced Spectral Mammography vs. MRI for Breast Cancer Screening | ||
| NCT02298348 | Sorafenib and Cyclophosphamide/Topotecan in Patients With Relapsed and Refractory Neuroblastoma | ||
| NCT04545957 | Jump: MR Simulation For Radiation Therapy Master Protocol | ||
| NCT02040857 | Palbociclib in Combination With Adjuvant Endocrine Therapy for Hormone Receptor Positive, HER2 Negative Invasive Breast Cancer | ||
| NCT00003657 | High-dose ICE With Amifostine | ||
| NCT01982448 | Cisplatin vs Paclitaxel for Triple Negative Breast Cancer | ||
| NCT00366457 | Gemcitabine, Bevacizumab and Erlotinib in Pancreatic Cancer | ||
| NCT00976248 | Everolimus (RAD001) in Primary Therapy of Waldenstrom's Macroglobulinemia | ||
| NCT04703426 | Sargramostim (GM-CSF) + PD-1 | ||
| NCT04386057 | LY3214996 +/- HCQ in Pancreatic Cancer | ||
| NCT06463457 | Comeback From Long coursE Androgen Deprivation Therapy (ADT) With RElugolix and Darolutamide (CLEARED) | ||
| NCT03060720 | Systematic Hereditary Pancreatic Cancer Risk Assessment and Implications for Personalized Therapy | ||
| NCT04781374 | Neratinib in Patients With Metastatic Castration-Resistant Prostate Cancer | ||
| NCT00137774 | Bevacizumab in Combination With Temozolomide in Patients With Neuroendocrine Tumors | ||
| NCT00575965 | Simvastatin in Waldenstrom's Macroglobulinemia | ||
| NCT06317220 | Vedolizumab for the Treatment of Collagenous Gastritis | ||
| NCT05482074 | Olaparib in Unresectable/Metastatic Melanoma With BRCA1/2 | ||
| NCT04323774 | Intervention For AYAS With Cancer Risk Syndromes |
